Phase II Trial of Lapatinib and Topotecan (LapTop) in Patients With Platinum-Refractory/Resistant Ovarian and Primary Peritoneal Carcinoma
Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2011.03.030
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2011
Authors
Publisher
Elsevier BV